Instrument Inactif

Autres langues SENSODETECT Swiss Exchange

Actions

SE0003037456

Equipement et technologie médicale avancés

Cours en clôture Swiss Exchange
- ^SEK	-

12/06	SensoDetect : dernière séance de cotation sur Spotlight avant radiation	FW
01/06	Spotlight retire Sensodetect de la cote - dernier jour de négociation le 12 juin	FW

Autres langues

27/05	SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2026
25/05	SensoDetect Inks Letter of Intent with UAE Partner to Explore ADHD Screening Initiative
27/02	SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
30/01	Sensodetect AB Announces Resignation of Board Members Pia Kinhult and Tore Robertsson
27/11	SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
24/11	SensoDetect Flag Strategic Talks on Neurodevelopmental Screening Tools With Saudi Arabia
14/11	SensoDetect: Successful Presentation at Redeye Theme: Medtech & Diagnostics – Demonstrating the Global Rollout of Objective Neuro-Auditory Screening
11/11	SensoDetect: SensoDetect to Present at Redeye Theme: Medtech & Diagnostics
10/11	SensoDetect: SensoDetect AB Announces Delegation Trip to China, 16–27 November 2025 and comments on delayed Q3 report
10/11	SensoDetect: SensoDetect advances Middle East expansion – introduces strategy for private school screening programs and SensoDetect-owned screening centers
31/10/25	SensoDetect Says AI System Testing in China JV Shows 'Very Promising' Results
31/10/25	SensoDetect's Chinese JV Closes Initial Investment Round
31/10/25	SensoDetect: SensoDetect AB Confirms receipt of license payments and announces successful installation and testing of AI software in China
31/10/25	SensoDetect: SensoDetect AB Announces Completion of Initial Investment Round for Beijing Mind Exploration Medical Technology Co., Ltd. (JV)
14/10/25	SensoDetect: Notification of Major Shareholding in SensoDetect AB
01/10/25	SensoDetect: SensoDetect accelerates international collaborations to advance early screening and diagnostic support tools for Autism and ADHD
29/09/25	SensoDetect: SensoDetect adds Dr Fatimah to its medical advisory board to boost data collection and drive autism study
26/09/25	SensoDetect: SensoDetect accelerates international autism study and expands data collection to fuel next-generation algorithms
25/09/25	SensoDetect: SensoDetect achieves AI breakthrough, unlocking scalable market leadership in neuropsychiatric diagnostics
23/09/25	SensoDetect: Sensodetect embarks on strategic business mission to China and the Middle East: showcasing next-generation AI diagnostics and future ABR+ERP (EEG) technology roadmap to large investors
19/09/25	SensoDetect: Sensodetect strengthens global clinical leadership: Dr. Mohamed Hussein Atwa Ahmed now permanently based in Sweden to drive expansion and investor value
29/08/25	SensoDetect Aktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
10/07/25	SensoDetect Plans Neuropsychiatric Diagnostics Ventures in China
10/07/25	SensoDetect: SensoDetect accelerates China expansion with new partnerships, breakthrough hardware, and strategic growth initiatives
01/07/25	SensoDetect: SensoDetect aims to capture 10% of a €6.8 Billion ASD and ADHD Diagnostics Market